Esketamine Nasal Spray Beneficial for Treatment-Resistant Depression

THURSDAY, Oct. 5, 2023 -- For patients with treatment-resistant depression, esketamine nasal spray is superior to extended-release quetiapine with respect to remission at week 8, according to a study published in the Oct. 5 issue of the New England...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news